Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -199.61M | -3446.88% | $ 5.79M |
3/31/2025 | $ -178.85M | -2366.07% | $ 7.56M |
12/31/2024 | $ -157.86M | -2248.76% | $ 7.02M |
9/30/2024 | $ -154.08M | -1544.48% | $ 9.98M |
6/30/2024 | $ -150.22M | -1809.4% | $ 8.3M |
3/31/2024 | $ -144.88M | -2385.97% | $ 6.07M |
12/31/2023 | $ -141.43M | -2054.76% | $ 6.88M |
9/30/2023 | $ -124.61M | -2854.75% | $ 4.37M |
6/30/2023 | $ -113.13M | -3475.7% | $ 3.25M |
3/31/2023 | $ -118.64M | -3766.22% | $ 3.15M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for CELLDEX THERAPEUTICS INC is calculated as follows: EBIT [ $ -48.55M ] / Revenues [ $ 4.52M ]
(=) EBIT % [ -1074.46% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |